- Home
- SBFM vs SNES Comparison
SBFM vs SNES Comparison
Compare SBFM & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- SNES
- Stock Information
- Founded
- SBFM 2006
- SNES 2004
- Country
- SBFM United States
- SNES United States
- Employees
- SBFM N/A
- SNES N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- SBFM Health Care
- SNES Industrials
- Exchange
- SBFM Nasdaq
- SNES Nasdaq
- Market Cap
- SBFM 7.7M
- SNES 6.7M
- IPO Year
- SBFM N/A
- SNES 2016
- Fundamental
- Price
- SBFM $1.54
- SNES $5.14
- Analyst Decision
- SBFM Strong Buy
- SNES Strong Buy
- Analyst Count
- SBFM 1
- SNES 1
- Target Price
- SBFM $15.00
- SNES $10.00
- AVG Volume (30 Days)
- SBFM 183.7K
- SNES 285.0K
- Earning Date
- SBFM 08-15-2025
- SNES 08-07-2025
- Dividend Yield
- SBFM N/A
- SNES N/A
- EPS Growth
- SBFM N/A
- SNES N/A
- EPS
- SBFM N/A
- SNES N/A
- Revenue
- SBFM $36,234,578.00
- SNES $1,927,000.00
- Revenue This Year
- SBFM $192.48
- SNES $130.53
- Revenue Next Year
- SBFM N/A
- SNES $80.00
- P/E Ratio
- SBFM N/A
- SNES N/A
- Revenue Growth
- SBFM 35.51
- SNES 40.15
- 52 Week Low
- SBFM $1.17
- SNES $1.30
- 52 Week High
- SBFM $7.60
- SNES $6.48
- Technical
- Relative Strength Index (RSI)
- SBFM 57.58
- SNES 77.02
- Support Level
- SBFM $1.42
- SNES $4.68
- Resistance Level
- SBFM $1.75
- SNES $5.17
- Average True Range (ATR)
- SBFM 0.12
- SNES 0.48
- MACD
- SBFM 0.01
- SNES 0.13
- Stochastic Oscillator
- SBFM 61.81
- SNES 87.29
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.